Rising Up: Interim 24-week analysis
收藏官方服务：
资源简介：
A phase 3 randomized, multi-center, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients in Japan with moderate-to-severe atopic dermatitis (Rising Up): Interim 24-week analysis
一项旨在评估乌帕替尼（upadacitinib）联合外用糖皮质激素（topical corticosteroids）治疗日本中重度特应性皮炎（atopic dermatitis）青少年及成人患者安全性的Ⅲ期随机多中心双盲临床试验（研究代号：Rising Up）：24周中期分析
创建时间：
2024-01-31
